Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007279:Injections, Subcutaneous; D009369:Neoplasms / Q000188:drug therapy; D011788:Quality of Life; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin